10.55 USD
▼-0.27-2.50%
盘后 10.45 -0.95%
2026-09-15
市值
$750.09M
市盈率
80.65
EPS
0.13
股息率
—
52 周区间
9.62 – 21.34
成交量
15.27K
Beta
0.07
目标价
34.35
52W 低 9.6252W 高 21.34
价格走势
公司简介
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also dev...